Zeta HPV Antibody Cocktail. Zeta’s recombinant antibody cocktail contains two defined monoclonals that recognize HPV. Human papilloma viruses (HPVs) can be classified as either high risk or low risk according to their association with cancer. HPV16 and HPV18 are the most common of the high-risk group while HPV6 and HPV11 are among the low risk types. Approximately 90% of cervical cancers contain HPV DNA of the high-risk types. Mutational analysis has shown that the E6 and E7 genes of the high-risk HPVs are necessary and sufficient for HPV transforming function. The Zeta HPV antibody cocktail reacts very strongly with formalin-fixed, paraffin-embedded tissues containing HPV-16, -18 or -33.
Zeta Corporation is a leader in recombinant monoclonal IVD antibodies for immunohistochemistry (IHC) offering 400+ tumor and tissue specific relevant products developed by a pathologist for pathologists. Visit Precision Recombinant Antibodies – IVD Antibodies – About Zeta Corporation (zeta-corp.com) to learn more about Zeta Corporation.